Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Construction and validation of a machine learning-based prediction model for in-hospital acute kidney injury in patients with lung cancer complicated with sepsis: clinical and nursing applications.

Journal of thoracic disease·2026

Same author

Adaptive Evolution of Serotype O Foot-and-Mouth Disease Virus Under Vaccine Pressure: Combined VP1 T142/Q153 Mutations Drive Antigenic Alteration and Immune Evasion.

Transboundary and emerging diseases·2026

Same author

Suppressor tRNA-mediated conditionally replicating live vaccine effectively protects pigs against Seneca Valley virus challenge.

NPJ vaccines·2026

Same author

ZNF33B Promotes Japanese Encephalitis Virus Infection by Regulating the Stability of M<sup>6</sup>A-Modified Trim25 to Control the Autophagy Process.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Same author

CALR-dependent endoplasmic reticulum N-glycoprotein maturation promotes Japanese encephalitis virus entry and replication.

Cell & bioscience·2026

Same author

Thioamide Compound H0802 Enhances Hypoxia Tolerance by Mimicking Hypoxia-Adaptive Reprogramming of Glucose and Oxygen Metabolism.

Antioxidants (Basel, Switzerland)·2026

Search research articles

Related Experiment Video

Updated: Feb 2, 2026

MAME Models for 4D Live-cell Imaging of Tumor: Microenvironment Interactions that Impact Malignant Progression

MAME Models for 4D Live-cell Imaging of Tumor: Microenvironment Interactions that Impact Malignant Progression

Published on: February 17, 2012

Research progress on GP73 in malignant tumors.

Rong Liang¹, Ziyu Liu¹, Xuemin Piao¹

¹Department of Medical Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, People's Republic of China, linyanmgx@163.com.

Oncotargets and Therapy

|November 15, 2018

Summary

Early diagnosis of malignant cancer improves survival rates. GP73, a novel serum tumor marker, shows promise for early liver cancer detection and targeted anticancer therapy.

Keywords:

GP73 diagnosis malignant tumors prognosis tumor marker

More Related Videos

Detection of Lung Tumor Progression in Mice by Ultrasound Imaging

Detection of Lung Tumor Progression in Mice by Ultrasound Imaging

Published on: February 27, 2020

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

Related Experiment Videos

Last Updated: Feb 2, 2026

MAME Models for 4D Live-cell Imaging of Tumor: Microenvironment Interactions that Impact Malignant Progression

MAME Models for 4D Live-cell Imaging of Tumor: Microenvironment Interactions that Impact Malignant Progression

Published on: February 17, 2012

Detection of Lung Tumor Progression in Mice by Ultrasound Imaging

Detection of Lung Tumor Progression in Mice by Ultrasound Imaging

Published on: February 27, 2020

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

Area of Science:

Oncology
Biochemistry
Molecular Biology

Background:

Malignant cancer poses a significant global health threat, with late-stage diagnosis leading to poor treatment outcomes and low survival rates.
Early tumor detection is crucial for improving patient prognosis, as evidenced by an 80% 5-year survival rate for early-stage cancers.
Serum tumor markers are vital tools for the early diagnosis of malignant cancers.

Purpose of the Study:

To investigate the diagnostic value of GP73 as a serum tumor marker for primary liver cancer.
To explore the potential of GP73 in targeted anticancer therapy.

Main Methods:

Review of recent studies on GP73 expression and its diagnostic utility.
Analysis of GP73's role as a transmembrane protein in cancer biology.

Main Results:

GP73 demonstrates significant diagnostic value for primary liver cancer, potentially exceeding that of other cancer types.
Research into GP73 expression regulation indicates promising avenues for targeted anticancer therapies.

Conclusions:

GP73 represents a promising novel tumor marker for the early detection of liver cancer.
Further research into GP73 is warranted due to its potential in both early diagnosis and targeted cancer treatment.